Cormark Analysts Give Vitalhub (TSE:VHI) a C$7.50 Price Target

Cormark set a C$7.50 price target on Vitalhub (TSE:VHI) in a report published on Monday, BayStreet.CA reports. The brokerage currently has a buy rating on the stock. Cormark also issued estimates for Vitalhub’s FY2025 earnings at $0.26 EPS.

A number of other research analysts have also commented on VHI. Eight Capital lifted their price objective on shares of Vitalhub from C$5.00 to C$6.25 and gave the company a buy rating in a research note on Tuesday, February 6th. Canaccord Genuity Group boosted their price target on shares of Vitalhub from C$5.25 to C$5.50 and gave the stock a buy rating in a research note on Tuesday, February 6th.

Vitalhub Trading Down 3.0 %

Vitalhub stock opened at C$6.40 on Monday. The stock has a market cap of C$279.74 million, a P/E ratio of 64.00, a price-to-earnings-growth ratio of 0.42 and a beta of 1.21. The company has a fifty day simple moving average of C$6.05 and a 200-day simple moving average of C$4.57. Vitalhub has a 12-month low of C$2.35 and a 12-month high of C$6.86.

Vitalhub (TSE:VHI) last released its quarterly earnings data on Thursday, March 21st. The company reported C$0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.04 by C($0.01). Vitalhub had a return on equity of 5.78% and a net margin of 8.66%. The firm had revenue of C$13.60 million for the quarter, compared to analysts’ expectations of C$13.68 million. As a group, sell-side analysts forecast that Vitalhub will post 0.1501823 earnings per share for the current fiscal year.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.